American Well Corp Cash Flow Conversion Efficiency
American Well Corp cash flow conversion efficiency. Based on the latest financial reports, American Well Corp (AMWL) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-983.00K) by net assets ($240.12 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of American Well Corp (2018–2025)
Cash flow conversion efficiency of American Well Corp from 2018 to 2025. This chart illustrates how American Well Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View American Well Corp stock price for real-time trading data and today's change.
American Well Corp Cash Flow Conversion Ratio Explained
American Well Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
American Well Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of American Well Corp ranked by their cash flow conversion efficiency. Also see American Well Corp stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MOLECULAR PARTNERS ADS/1
F:6ML0
|
-0.184x |
|
Excelliance MOS
TWO:5299
|
0.024x |
|
Innate Pharma
NASDAQ:IPHA
|
1.078x |
|
Navkar Corporation Limited
NSE:NAVKARCORP
|
0.015x |
|
Fu Chun Shin Machinery Manufacture Co Ltd
TWO:6603
|
0.029x |
|
AMIA Co. Ltd.
TW:8438
|
0.062x |
|
Paragon Globe Bhd
KLSE:3611
|
-0.008x |
|
Raba Jarmuipari Holding Nyrt
BUD:RABA
|
-0.007x |
Annual Cash Flow Conversion Efficiency for American Well Corp (2018–2025)
The table below shows the annual cash flow conversion efficiency of American Well Corp from 2018 to 2025. Review AMWL free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $247.79 Million | $-65.95 Million | -0.266x | +33.90% |
| 2024-12-31 | $316.24 Million | $-127.34 Million | -0.403x | -30.34% |
| 2023-12-31 | $480.19 Million | $-148.34 Million | -0.309x | -74.10% |
| 2022-12-31 | $1.08 Billion | $-192.32 Million | -0.177x | -58.08% |
| 2021-12-31 | $1.26 Billion | $-141.54 Million | -0.112x | -24.39% |
| 2020-12-31 | $1.25 Billion | $-112.46 Million | -0.090x | +58.68% |
| 2019-12-31 | $374.94 Million | $-81.89 Million | -0.218x | -160.33% |
| 2018-12-31 | $-204.41 Million | $-74.01 Million | 0.362x | -- |
About American Well Corp
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transfor… Read more